Diabetes
Get a 360º view and stay up-to-date on diabetes with content selected for you
Safe, Flexible & Proven- Gen 2.0 basal insulin supporting individualized basal insulin therapy
Watch Dr.Steven Edelman discuss the clinical evidence behind basal insulin therapy and explore how safe, flexible and proven insulin coverage can support individualized diabetes management across diverse patient profiles.
Safe, Flexible and Proven: Gen 2.0 Basal Insulin therapy across diverse population including elderly patients and those with varying degrees of CKD and comorbidities.
Here’s a podcast starring Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across a wide spectrum of Diabetes populations, including older adults and those with renal impairment and associated co-morbidities.
Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy for consistent and predictable outcomes
Featuring a podcast with Dr. Steven Edelman, where he reviews the evidence behind a second-generation basal insulin like Gla-300 and its ability to provide consistent and predictable basal insulin coverage with once-daily administration, supporting simplified and individualized diabetes management.
Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy to match daily life needs of people with T2DM
Here's a podcast starring Pr. Stewart Harris and Pr. Othmar Moser, discussing the importance of simple dosing and titration, flexible to match daily life needs
Safe, Flexible and Proven: Gen 2.0 Basal Insulin Therapy Across Diverse T2D Populations
Join Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across diverse Type 2 diabetes populations, including older adults and those with renal impairment.
Soli-SWITCH study
Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes
Soli-CGM study
Effect of iGlarLixi on continuous glucose monitoring measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes
Fixed Ratio Combination in Diabetes Care Webinar Key Takeaway
Fixed Ratio Combination (FRC) simplify diabetes management by combining complementary agents in a single injection. Our webinar explored the clinical evidence and practical applications of FRC therapies in managing type 2 diabetes. Watch this exclusive video to explore the key highlights from the Fixed Ratio Combination in Diabetes Care Webinar
Recent Updates
Safe, Flexible & Proven- Gen 2.0 basal insulin supporting individualized basal insulin therapy
Watch Dr.Steven Edelman discuss the clinical evidence behind basal insulin therapy and explore how safe, flexible and proven insulin coverage can support individualized diabetes management across diverse patient profiles.
Safe, Flexible and Proven: Gen 2.0 Basal Insulin therapy across diverse population including elderly patients and those with varying degrees of CKD and comorbidities.
Here’s a podcast starring Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across a wide spectrum of Diabetes populations, including older adults and those with renal impairment and associated co-morbidities.
Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy for consistent and predictable outcomes
Featuring a podcast with Dr. Steven Edelman, where he reviews the evidence behind a second-generation basal insulin like Gla-300 and its ability to provide consistent and predictable basal insulin coverage with once-daily administration, supporting simplified and individualized diabetes management.
Safe, Flexible & Proven- Gen 2.0 Basal Insulin Therapy to match daily life needs of people with T2DM
Here's a podcast starring Pr. Stewart Harris and Pr. Othmar Moser, discussing the importance of simple dosing and titration, flexible to match daily life needs
Safe, Flexible and Proven: Gen 2.0 Basal Insulin Therapy Across Diverse T2D Populations
Join Dr. Alice Cheng as she reviews the evidence behind second-generation basal insulins and their role in delivering safe, flexible, and proven glycemic control across diverse Type 2 diabetes populations, including older adults and those with renal impairment.
Soli-SWITCH study
Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes
Guidelines
GLOBAL & INDIAN BURDEN OF DIABETES WITH ITS PATHOPHYSIOLOGY & PROGRESSION OF THE DISEASE
GLOBAL & INDIAN BURDEN OF DIABETES WITH ITS PATHOPHYSIOLOGY & PROGRESSION OF THE DISEASE
Clinical Studies
Insulin Initiation
InsulinToolKit
Are you looking for a simplification tool for insulin initiation and titration in your patients? The wait is over.
InsulinToolKit is a Decision Support tool designed to support patients with initiation and titration of their insulin regimes in a simplified manner to help optimize glycemic control.
Time in Range
Choice of Insulin
Congress Highlights
Webinar Key Take Away
Fixed Ratio Combination in Diabetes Care Webinar Key Takeaway
Fixed Ratio Combination (FRC) simplify diabetes management by combining complementary agents in a single injection. Our webinar explored the clinical evidence and practical applications of FRC therapies in managing type 2 diabetes. Watch this exclusive video to explore the key highlights from the Fixed Ratio Combination in Diabetes Care Webinar
leave-site-modal-text
You are now being redirected to a third-party website.
Sanofi does not endorse or approve the content, products, services or opinions on the third-party website. Sanofi shall not be responsible or in any way liable for any injury or damage to any persons in view of any reliance placed on or action taken basis of the information on the third party website or any errors, omissions or inaccuracies and/or incompleteness of the information on the third party website.
Patient-Information-Sketch
Option-1
Right answer: Both A and B. As per Diabetic & Ramadan guidelines, T2DM patients can safely continue glargine U-100 once daily at a reduced dose of 15 - 30% at Iftar1,2. Insulin glargine U-100 is safe to be used during Ramadan with no significant increase in hypoglycaemia3. One-on-one dietary educational session can also reduce the number of adverse events of fasting1.
Toujeo-interactive-popup-1
Toujeo-interactive-popup-2
Toujeo-interactive-popup-3
A-single-dose-of-Glulisine-Glargine-video
Basal-plus-regime-Simple-Effective-Low-risk-of-hypoglycemia